All Articles

A new AI-powered platform claims to offer unprecedented transparency into the volatile world of strategic minerals, vital for the global green economy.

After a transformative year with key FDA/EU approvals, Pulsenmore's financials get a one-time boost. Can it now conquer the remote prenatal care market?

A new three-season deal with the Timberwolves and Lynx sees baby gear brand Joie invest in community, equity, and a new model for family-focused partnership.

Husqvarna's new residential mowers boast major comfort and durability upgrades, heating up the spring sales battle against John Deere, Toro, and Cub Cadet.

LIB Therapeutics' new monthly, room-temperature stable cholesterol drug shows strong long-term data, challenging rivals with a focus on patient ease-of-use.

Ottawa and provinces make key strides in dismantling internal trade barriers, unlocking a potential $210 billion boost to Canada's economy. Here's what it means.

Fancamp Exploration is splitting into two companies, creating a stable royalty firm and a high-stakes gold explorer, Goldera, to unlock shareholder value.

DERMAFLASH launches its first sonic dermaplaning system for pros, promising a safer, more effective alternative to traditional scalpel-based treatments.

A new solution promises zero-downtime migration to IBM's MAS, tackling a major hurdle for asset-intensive industries facing a critical support deadline.

With a $700M war chest and a new veteran president, MISSION Underwriters aims to disrupt Latin America's facultative reinsurance market with its tech platform.

Clearwater Paper launches Velora™, a new lightweight paperboard balancing cost, sustainability, and domestic supply to capture the everyday packaging market.

Bowhead Specialty signals a major focus on its tech-driven underwriting, scheduling key events to detail its digital growth engine ahead of its May 5th report.

As $50B in federal funds flow to rural health, Ovatient's new platform aims to create a sustainable virtual care model that will outlast the grants.

Japanese pharma giant Meiji Seika Pharma backs Centivax's quest for a universal flu vaccine, a move that could revolutionize global pandemic preparedness.

Australian medtech firm 4DMedical lands CE Mark for its revolutionary CT:VQ lung imaging, fueling a major European expansion with a fresh AU$83M investment.

Alex Oberberg joins S4 Capital's Monks as EMEA CRO, tasked with scaling AI systems and unifying marketing in a play for regional dominance.

Xplor Technologies and Clubessential merge, forming a $900M global leader with a new CEO and a bold eight-figure investment in artificial intelligence.

As Houston faces a multi-billion dollar infrastructure crisis, Del Monte Capital's investment in DLG Services signals a new push to fix its aging water systems.

An ETF offers retail investors a ticket to SpaceX's massive IPO, but a bitter public dispute with critics raises questions about transparency and risk.

A Georgia firm's painless patch technology earns top honors, promising to revolutionize medicine delivery and solve critical global health challenges.